Calcium Dobesilate Capsules
Belongs to Category:
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
Product Description
Approval Number:
H20203548
Indications:
1. Treatment of Microangiopathies:
Diabetic microangiopathies (retinopathy and glomerulosclerosis [Kimmelstiel-Wilson syndrome]).
Microvascular injuries associated with increased capillary fragility and permeability, capillary bleeding, and acrocyanosis.
2.Adjunctive Therapy for Chronic Venous Insufficiency (CVI):
Varicose vein syndromes and sequelae (post-thrombotic syndrome, leg ulcers, stasis dermatitis, peripheral edema, etc.).
Administration:
Diabetic Retinopathy: 1 capsule at a time, 3 times a day (morning, noon, evening).
Other Indications: 1 capsule at a a time, 2 times a day (morning and evening). If clinical improvement occurs, omit the evening dose after approximately 1 month.
Specifications:
0.5g × 36 capsules
The company has production licenses for tablets, capsules, granules, suppositories, powders, injections, oral solutions, dry suspensions, and eye drops.
The main products cover cardiovascular diseases, diabetic complications, anti-tumor, calcium supplementation, digestive system, respiratory system, and orthopedics.
Related Products
Online Message
We will contact you within one business day. Please pay attention to your email.
Email: marcos.yuan@wangao.com.cn
Address: No. 688, Dinghai Road, Haimen City, Jiangsu Province
Mobile Version QR Code
WeChat Official Account
Copyright © 2025 Jiangsu Wangao Pharmaceutical Co., Ltd.